Application of Magnetic Resonance Imaging in Neoadjuvant Treatment of Pancreatic Ductal Adenocarcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Magnetic Resonance Imaging"
DOI: 10.1002/jmri.28096
Abstract: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignant tumors of the human digestive system. Due to its insidious onset, many patients have already lost the opportunity for radical resection upon tumor diagnosis. In… read more here.
Keywords: magnetic resonance; neoadjuvant treatment; resonance imaging; pancreatic ductal ... See more keywords
Response to “Prognostic factors in patients with pancreatic ductal adenocarcinoma with neoadjuvant treatment and pancreatectomy”
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.26853
Abstract: We our study “ Predictors of early recurrence following neoadjuvant chemotherapy and surgical resection for localized pancreatic adenocarcinoma. We first want to clarify that we are strong proponents of neoadjuvant treatment (NAT) use in pancreatic… read more here.
Keywords: neoadjuvant treatment; response; ductal adenocarcinoma; pancreatic ductal ... See more keywords
Is there a correlation between HER2 gene amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2-positive breast cancer?
Sign Up to like & getrecommendations! Published in 2021 at "Virchows Archiv"
DOI: 10.1007/s00428-021-03104-7
Abstract: There are contradictory data regarding the correlation between HER2 amplification level determined by in situ hybridization and evolution after treatment with anti-HER2 therapies. The aim of this study was to correlate quantitative results of FISH… read more here.
Keywords: neoadjuvant treatment; her2; correlation her2; amplification ... See more keywords
Increasing Use of PET-CT, Neoadjuvant Treatment, Minimally Invasive Approach and Surgical Radicality in Esophageal Cancer Surgery are Associated with Improved Short- and Long-term Outcomes in Real-World Setting
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Gastrointestinal Surgery"
DOI: 10.1007/s11605-022-05279-z
Abstract: Guideline adherence has improved outcomes in several cancers. Our aim was to evaluate whether the rate of PET-CT, neoadjuvant treatment, minimally invasive approach, and surgical radicality, suggested also by recent guidelines, would improve short- and… read more here.
Keywords: group; esophageal cancer; pet neoadjuvant; minimally invasive ... See more keywords
The Evolving Neoadjuvant Treatment Paradigm for Patients with Locoregional mismatch Repair Proficient Rectal Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Current Treatment Options in Oncology"
DOI: 10.1007/s11864-022-00961-5
Abstract: The standard of care for locally advanced rectal cancer (LARC) has included preoperative chemoradiation, total mesorectal excision surgery and post operative adjuvant chemotherapy based on histopathology. The current therapeutic landscape in LARC has many different… read more here.
Keywords: chemotherapy; treatment; evolving neoadjuvant; rectal cancer ... See more keywords
Efficacy and Safety of Neoadjuvant Treatment with Bevacizumab, Liposomal Doxorubicin, Cyclophosphamide and Paclitaxel Combination in Locally/Regionally Advanced, HER2-Negative, Grade III at Premenopausal Status Breast Cancer: A Phase II Study
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Drug Investigation"
DOI: 10.1007/s40261-018-0655-z
Abstract: BackgroundIn the era of personalized therapy, targeted treatment in specific patient populations is mandated.ObjectiveWe evaluated the efficacy and safety of neoadjuvant treatment on locally advanced breast cancer (LABC) with a monoclonal agent against vascular endothelial… read more here.
Keywords: doxorubicin cyclophosphamide; breast; neoadjuvant treatment; treatment ... See more keywords
Imaging Response Evaluation after Neoadjuvant Treatment in Soft Tissue Sarcomas: Where Do We Stand?
Sign Up to like & getrecommendations! Published in 2021 at "Critical reviews in oncology/hematology"
DOI: 10.1016/j.critrevonc.2021.103309
Abstract: Soft tissue sarcomas (STS) represent a broad family of rare tumours for which surgery with radiotherapy represents first-line treatment. Recently, neoadjuvant chemo-radiotherapy has been increasingly used in high-risk patients in an effort to reduce surgical… read more here.
Keywords: soft tissue; response; neoadjuvant treatment; treatment ... See more keywords
Adjuvant and Neoadjuvant Treatment of Skin Cancer.
Sign Up to like & getrecommendations! Published in 2019 at "Facial plastic surgery clinics of North America"
DOI: 10.1016/j.fsc.2018.08.014
Abstract: Skin cancer represents a broad classification of malignancies, which can be further refined by histology, including basal cell carcinoma, squamous cell carcinoma and melanoma. As these three cancers are distinct entities, we review each one… read more here.
Keywords: treatment skin; adjuvant neoadjuvant; skin cancer; neoadjuvant treatment ... See more keywords
Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer
Sign Up to like & getrecommendations! Published in 2021 at "Modern Pathology"
DOI: 10.1038/s41379-021-00738-5
Abstract: The response of human epidermal growth factor receptor2 (HER2)- positive breast cancer (BC) patients to anti-HER2 targeted therapy is significant. However, the response is not uniform and a proportion of HER2-positive patients do not respond.… read more here.
Keywords: her2 positive; neoadjuvant treatment; response; her2 ihc ... See more keywords
Neoadjuvant treatment for borderline resectable pancreatic adenocarcinoma is associated with higher R0 rate compared to upfront surgery
Sign Up to like & getrecommendations! Published in 2021 at "Acta Oncologica"
DOI: 10.1080/0284186x.2021.1944662
Abstract: Abstract Background Neoadjuvant treatment (NAT) is debated for borderline resectable pancreatic cancer (BRPC). This retrospective study assessed the impact of NAT on R0 rate and survival for BRPC patients in comparison with upfront surgery (US).… read more here.
Keywords: rfs; resectable pancreatic; rate; borderline resectable ... See more keywords
Optimal adjuvant treatment strategies for TNBC patients with residual disease after neoadjuvant treatment.
Sign Up to like & getrecommendations! Published in 2023 at "Expert review of anticancer therapy"
DOI: 10.1080/14737140.2023.2218090
Abstract: INTRODUCTION The therapeutic armamentarium for the neoadjuvant treatment of triple-negative breast cancer (TNBC) has significantly expanded with the hopes of improving pathological complete response (pCR) rates and the possibility of a cure. However, the data… read more here.
Keywords: neoadjuvant treatment; treatment strategies; patients residual; optimal adjuvant ... See more keywords